Skip to main content
Fig. 5 | Renal Replacement Therapy

Fig. 5

From: Clinical characteristics of renal transplant recipients who developed de novo donor-specific antigen in Kyoto University Hospital: a case series

Fig. 5

Clinical course and change in serum creatinine level in case #3. Case 3 is a 27-year-old man with chronic glomerulonephritis who received an ABO-compatible transplant with her mother as the donor. CyA: cyclosporin A; PSL: prednisolone; AZA: azathioprine; MMF: mycophenolate mofetil; cABMR: chronic antibody-mediated rejection; DSA: donor-specific antigen; HD: hemodialysis

Back to article page